We can’t show the full text here under this license.
Abstract
K153E and K58I mutations in hemagglutinin resulted in enhanced immune responses in mice vaccinated with modified mRNA-LNP vaccines.
- Four specific mutations (E47K, K58I, R106K, and K153E) were introduced to improve hemagglutinin stability.
- K153E and K58I mutations increased the presence of hemagglutinin on the cell surface in vitro.
- In mice, K153E and K58I-containing vaccines led to higher neutralizing antibody levels against the homologous virus.
- Vaccination with K153E provided better protection against a lethal heterologous virus challenge at low doses, despite lacking neutralizing antibodies against that strain.
- K153E also promoted a greater increase in specific antibody-secreting cells in the bone marrow and cross-reactive helper T cells in the spleen.
- Enhanced hemagglutinin expression correlated more strongly with immune response enhancement than hemagglutinin stability.
Simplified